6 completed, 3 recruiting. 5 Phase 3, 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Prevnar®: new trials by email Literature Review of Prevnar® trials Research Report on Prevnar®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease | Phase 2 | Recruiting | Sinovac Life Sciences Co., Ltd. | 420 | 2025-11-25 | 2025-12-24 |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease | Phase 1 | Recruiting | Sinovac Life Sciences Co., Ltd. | 180 | 2025-05-08 | 2026-01-28 |
| Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine Sinovac PCV13, Prevnar® - Pneumococcal Infectious Disease | Phase 3 | Recruiting | Sinovac Life Sciences Co., Ltd. | 3080 | 2024-10-23 | 2026-01-28 |
| Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age GSK Biological's investigational vaccine 209762, M-M-R® II (Merck and Co), Varivax® - Rubella, Mumps | Phase 2 | Completed | GlaxoSmithKline | 1259 | 2009-06-03 | 2020-01-03 |
| Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age Priorix-Tetra™ (MMRV vaccine 208136), ProQuad®, Havrix® - Varicella, Rubella | Phase 2 | Completed | GlaxoSmithKline | 1851 | 2007-11-20 | 2018-10-09 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants Meningococcal ACWY Conjugate Vaccine, DTaP-IPV-HBV, Hib - Meningitis, Meningococcal | Phase 3 | Completed | Novartis Vaccines | 4545 | 2007-03-01 | 2014-03-24 |
| Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines, DTaP-HB-IPV and Pneumococcal polysaccharide vaccines - Hepatitis B, Polio | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 412 | 2006-10-01 | 2014-04-01 |
| A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Meningococcal Polysaccharide Diphtheria Toxoid Conjugate - Meningococcal Meningitis, Measles | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1128 | 2006-09-01 | 2016-04-14 |
| Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar® - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi | 1167 | 2003-10-01 | 2012-02-01 |
Haemophilus Infections (3) · Measles (3) · Mumps (3) · Pneumococcal Infections (3) · Rubella (3) · Chickenpox (2) · Diphtheria (2) · Meningitis, Meningococcal (2) · Poliomyelitis (2) · Whooping Cough (2) · Hepatitis B (1) · Meningitis (1) · Meningococcal Infections (1) · Tetanus (1)
Sinovac Life Sciences Co., Ltd. (3) · GlaxoSmithKline (2) · Sanofi Pasteur, a Sanofi Company (2) · Novartis Vaccines (1) · Sanofi (1)
United States (5) · China (3) · Argentina (1) · Colombia (1) · Puerto Rico (1) · Thailand (1)
Qing Xu (1) · Yanxia Wang (1)